Clinical Trial Update: Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder. [Phase 4]

View source ↗

Summary

Phase 4 trial update investigates lisdexamfetamine dimesylate for residual symptoms and cognitive impairment in major depressive disorder; results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Vyvanse (lisdexamfetamine dimesylate)

Snippet

Sponsor: Mclean Hospital | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED | Results posted: 2017-05-23